CND Life Sciences
ApprovedCND advances neurodiagnostics through skin biopsy testing, including the Syn-One Test, for neurodegenerative diseases.
Founded
2003
Focus
Diagnostics
About
CND advances neurodiagnostics through skin biopsy testing, including the Syn-One Test, for neurodegenerative diseases.
Funding History
2Total raised: $68M
Series B$43MLabcorpFeb 15, 2023
Series A$25MGreycroftJun 15, 2021
Company Info
TypePrivate
Founded2003
LocationScottsdale, United States
StageApproved
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile